Insmed Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Insmed Inc.
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.
/ 
Frequently asked questions
To buy Insmed Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Insmed Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Insmed Inc. is INSM:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Insmed Inc. has its primary listing on NASDAQ (Small cap). You can trade Insmed Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Insmed Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Insmed Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Insmed Inc..